Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease (BENEFIT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by Population Health Research Institute.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
World Health Organization
Instituto Dante Pazzanese de Cardiologia
University of Sao Paulo
Information provided by:
Population Health Research Institute
ClinicalTrials.gov Identifier:
NCT00123916
First received: July 21, 2005
Last updated: August 1, 2011
Last verified: June 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):